Fig. 3From: An international comparative analysis of public reimbursement of orphan drugs in Canadian provinces compared to European countriesHTA Recommendation* Stratified by Incidence of Rare Disease. *This analysis was conducted for the CADTH HTA recommendationsBack to article page